Hedge Fund - Acuta Capital Partners
Viridian Therapeutics Inc. ()
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q3 (2024-09-30) | $0 | 0% | 0 | $ |
| 2 | 2024 - Q2 (2024-06-30) | $2,594,623 | 2.18% | 199,433 | $ |
| 3 | 2024 - Q1 (2024-03-31) | $3,492,072 | 2.26% | 199,433 | $ |
| 4 | 2023 - Q4 (2023-12-31) | $6,131,070 | 3.45% | 281,500 | $ |
| 5 | 2023 - Q3 (2023-09-30) | $3,441,360 | 2.3% | 224,339 | $ |
| 6 | 2023 - Q2 (2023-06-30) | $5,345,780 | 3.62% | 224,707 | $ |
| 7 | 2023 - Q1 (2023-03-31) | $4,273,920 | 3.14% | 168,000 | $ |
| 8 | 2022 - Q4 (2022-12-31) | $11,581,765 | 7.12% | 396,500 | $ |
| 9 | 2022 - Q3 (2022-09-30) | $7,440,000 | 3.2% | 362,735 | $ |
| 10 | 2022 - Q2 (2022-06-30) | $2,708,000 | 1.5% | 234,026 | $ |
| 11 | 2022 - Q1 (2022-03-31) | $6,287,000 | 2.93% | 340,000 | $ |
| 12 | 2021 - Q4 (2021-12-31) | $6,287,000 | 2.64% | 318,000 | $ |
| 13 | 2021 - Q3 (2021-09-30) | $2,234,000 | 0.78% | 135,807 | $ |
The displayed share prices are average quarterly stock market prices.